News und Analysen
GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections Four Years After One-Time Administration
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240319984906/en/
Graph 1: Evolution of Best-Corrected Visual Acuity
Is It Too Late to Buy Green Thumb Industries Stock?
It's easy to see why investors might suspect that Green Thumb Industries' (OTC: GTBIF) best days are behind it. The wild times of the 2021 marijuana stock bull market that saw its shares fly are in
Could Baidu Stock Help You Become a Millionaire?
Baidu (NASDAQ: BIDU) likely minted a few millionaires after its public debut in 2005. If you had invested $10,000 in the Chinese tech giant's IPO, your investment would have briefly blossomed to
Could Baidu Stock Help You Become a Millionaire?
Baidu (NASDAQ: BIDU) likely minted a few millionaires after its public debut in 2005. If you had invested $10,000 in the Chinese tech giant's IPO, your investment would have briefly blossomed to
Forget About the "Magnificent Seven." Here's One Stock to Consider in 2024.
The "Magnificent Seven" is a group of tech stocks that delivered solid returns in 2023, propelling the S&P 500 index to greater heights.
But just because these giants outperformed in 2023 does not
Is Costco Stock Going to $800? 1 Analyst Thinks So
Costco Wholesale (NASDAQ: COST) stock has been reaching new highs in 2024, but it could have more room to run. The warehouse club retailing giant received another analyst upgrade late Monday, which
Is Costco Stock Going to $800? 1 Analyst Thinks So
Costco Wholesale (NASDAQ: COST) stock has been reaching new highs in 2024, but it could have more room to run. The warehouse club retailing giant received another analyst upgrade late Monday, which
GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ® Gene Therapy at NANOS 2024
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240311531952/en/
Figure 1. Visual Recovery (CRR from Nadir) Among
1 Wall Street Analyst Warns That 3M Stock Has 9% Downside Risk
With a forward P/E ratio of less than 10, and a great dividend yield of 6.5%, industrial conglomerate 3M Company (NYSE: MMM) looks for all the world like a high quality large-cap dividend stock
1 Wall Street Analyst Warns That 3M Stock Has 9% Downside Risk
With a forward P/E ratio of less than 10, and a great dividend yield of 6.5%, industrial conglomerate 3M Company (NYSE: MMM) looks for all the world like a high quality large-cap dividend stock
ChargePoint Stock Has 50% Upside, According to 1 Wall Street Analyst
ChargePoint's (NYSE: CHPT) sales and margins have dropped off in recent quarters, and the electric vehicle (EV) charging company even announced layoffs recently to save money. ChargePoint
ChargePoint Stock Has 50% Upside, According to 1 Wall Street Analyst
ChargePoint's (NYSE: CHPT) sales and margins have dropped off in recent quarters, and the electric vehicle (EV) charging company even announced layoffs recently to save money. ChargePoint
2 Cannabis Stocks to Buy Hand Over Fist in March
Investing in cannabis isn't easy. It requires a lot of patience. While the majority of Americans are in favor of legalizing marijuana, that doesn't mean that regulators have made it a priority to
GenSight Biologics Announces Update on Real-World Data from Early Access Programs of LUMEVOQ® Gene Therapy at NANOS 2024
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240305810568/en/
(Graphic: Business Wire)
GenSight Biologics
2 Stocks That Can Bounce Back in March
Stocks are rolling this month. The major market indexes hit all-time highs on the first trading day of March. There are plenty of high fives to go around. Let's take a look at some of the "down low
2 Stocks That Can Bounce Back in March
Stocks are rolling this month. The major market indexes hit all-time highs on the first trading day of March. There are plenty of high fives to go around. Let's take a look at some of the "down low
Baidu (BIDU) Q4 2023 Earnings Call Transcript
Baidu (BIDU) Q4 2023 Earnings Call Transcript
Why Baidu, Alibaba, and Other Chinese Stocks Sank on Wednesday
Stocks of some of China's most widely held companies were sinking in unison on Wednesday, with several catalysts sending them lower. One company delivered a disappointing financial report, concerns
Medical Properties Trust Stock Has 21% Upside, According to 1 Wall Street Analyst
With shares of Medical Properties Trust (NYSE: MPW) falling by 61% in the last 12 months, shareholders will be happy to hear that, at least in the eyes of certain people on Wall Street, the company
Medical Properties Trust Stock Has 21% Upside, According to 1 Wall Street Analyst
With shares of Medical Properties Trust (NYSE: MPW) falling by 61% in the last 12 months, shareholders will be happy to hear that, at least in the eyes of certain people on Wall Street, the company
Top Picks From Wall Street: 2 Magnificent Growth Stocks to Buy Now and Hold Long-Term
BMO Capital selected Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) as a top pick in 2024, citing its long-standing leadership in artificial intelligence (AI). Analysts noted that its Google subsidiary has
Top Picks From Wall Street: 2 Magnificent Growth Stocks to Buy Now and Hold Long-Term
BMO Capital selected Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) as a top pick in 2024, citing its long-standing leadership in artificial intelligence (AI). Analysts noted that its Google subsidiary has
This Ultra-High-Yield Dividend Stock Takes Another Page Out of Devon Energy's Playbook
Devon Energy (NYSE: DVN) launched a pioneering capital return framework following its transformational merger with WPX Energy in early 2021. It established the industry's first fixed-plus-variable
1 Growth Stock Down 70% You'll Wish You'd Bought at Today's Near-All-Time-Low Valuation
Despite becoming the dominant e-commerce force in South Korea in just over a decade, Coupang (NYSE: CPNG) has seen its stock decline by 70% since its 2021 initial public offering. This divergence